Risk, Best Treatment May Be Guided By Newly Identification Acute Myeloid Leukemia Gene Mutations
3/26/2012
An international group of researchers, including those from Moffitt Cancer Center in Tampa, Fla., have published a paper in the New England Journal of Medicine reviewing the results of a study that analyzed mutations in 18 genes of 398 patients who had acute myeloid leukemia (AML)...
Reducing Lung Cancer Deaths Using Lower Dosage CT-Guided Lung Biopsy Protocol
3/26/2012
New imaging parameters rein in incremental radiation dose from potentially life-saving CT-guided biopsy of lung nodules to reduce patients' overall exposure. New guidelines for CT-guided biopsies of lung nodules significantly reduce radiation exposure allowing individuals the benefit of the procedure, which may cut down on overall lung cancer deaths...
New Cancer Test Enlists Microbe In Pond Scum
3/26/2012
Scientists are enlisting the living, self-propelled microbes found in pond scum - the pea-green surface slicks that form on ponds - in the development of a long-awaited new test to detect the cells that spread cancer through the bloodstream from the original tumor to new sites in the body...
Cancer Cells Deterred By 'Bed-Of-Nails' Breast Implant
3/26/2012
Researchers at Brown University have created an implant that appears to deter breast cancer cell regrowth. Made from a common federally approved polymer, the implant is the first to be modified at the nanoscale in a way that causes a reduction in the blood-vessel architecture that breast cancer tumors depend upon, while also attracting healthy breast cells. Results are published in Nanotechnology...
New Mechanism Of Prostate Cancer Cell Metabolism Identified
3/26/2012
Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells. Study results are published in Cancer Discovery, a journal of the American Association for Cancer Research. Almut Schulze, Ph.D., a group leader in the Gene Expression Analysis Laboratory at Cancer Research U.K...
Liver Cancer Patients Less Likely To Die On Wait List Than Candidates Without Carcinomas
3/26/2012
New research shows increasing disparity in mortality among candidates with and without hepatocellular carcinoma (HCC) who are on the waiting list for liver transplantation...
Mutations Detected Within A Brain Tumor Using Non-Invasive Imaging
3/26/2012
Researchers at Winship Cancer Institute have developed a technique for detecting an "oncometabolite," a chemical produced by some brain tumors' warped metabolism, via non-invasive imaging. Their approach could allow doctors to know not only that a brain tumor is there, but also that it carries a particular genetic mutation...
Unhealthy Behaviors More Prevalent In Survivors Of Multiple Cancers, Study Shows
3/26/2012
A study published by University of Kentucky researchers shows that survivors of multiple cancers report unhealthier behaviors post-diagnosis than control counterparts. Published in the Annals of Behavioral Medicine, the study recorded answers regarding health status and health behaviors from 404,525 adults using the Behavioral Risk Factor Surveillance System survey...
Testosterone May Play A Role In Triple Negative Breast Cancer
3/26/2012
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring...
Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs
3/26/2012
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA...